生物标志物 生物标志物
Jan Muntel1,2, Aida Kamalian3, Polina Shichkova1
1Biognosys AG, Schlieren, Zurich, Switzerland.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究确定了用于早期阿尔茨海默病检测的新型血生物标志物,先于认知衰退和粉样蛋白转化. 这些发现为当前的诊断方法提供了一个不那么侵入性的替代方案.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 生物标志物发现发现
背景情况:
- 衰老是阿尔茨海默氏症 (AD) 的主要危险因素,但从健康到病态衰老的过渡不清楚.
- 早期发现AD至关重要,需要在认知症状或粉样蛋白转化之前检测到的生物标志物.
- 由于其可访问性和非侵入性,等离子体是生物标志物发现的理想矩阵.
研究的目的:
- 开发一种基于质谱 (MS) 的新型蛋白质组学工作流程,用于在血中发现无偏的生物标志物.
- 识别与认知衰退和阿尔茨海默病进展相关的早期分子变化.
- 发现血基生物标志物,这些生物标志物先于粉样蛋白转化和临床症状.
主要方法:
- 从BIOCARD队列中选择的参与者,根据10年的CSF Aβ42 / Aβ40比率将55个分类为粉样蛋白转化剂和55个匹配的非转化剂.
- 分析了578个血样本,使用一种基于MS的新型蛋白质组学工作流 (Biognosys P2) 涉及预处理,消化和定量质谱.
- 收集的纵向数据包括认知评估,临床生物标志物和MRI扫描.
主要成果:
- 质谱学揭示了与认知衰退和过渡到轻度认知障碍 (MCI) 相关的蛋白质和变化.
- 确定了关键的生物途径,包括脂质代谢,细胞外矩阵重塑,轴突生成和突触活动.
- 发现了在粉样蛋白转化和认知衰退之前存在的基于血的特征,在临床转化之前可以检测到.
结论:
- 一种综合方法将AD的分子变化与临床表型联系起来.
- 血衍生生物标志物为AD诊断提供了脑脊液 (CSF) 采集的不那么侵入性的替代方案.
- 这项研究强调了血蛋白质组学在早期AD检测和了解疾病机制方面的潜力.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


